Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 11, 2025
The Impact of Cost Cutting on MD-PhD Programs in Canada: Equity, Diversity, and Inclusion Challenges for Clinician-Scientist Training ProgramsAnna Frumkin, Grace Yu, Kaiyang Li, et al.
Family Medicine and Community Health|May 12, 2023
Biopsy of Canada's family physician shortageKaiyang Li, Anna Frumkin, Wei Guang Bi, et al.
Clinical & Experimental Metastasis|January 13, 2024
Mapping the single cell spatial immune landscapes of the melanoma microenvironmentJamie Magrill, Dan Moldoveanu, Jiayao Gu, et al.
Materials (Basel, Switzerland)|December 24, 2021
Antimicrobial Activity of 3D-Printed Acrylonitrile Butadiene Styrene (ABS) Polymer-Coated with Silver NanoparticlesIsabel Tse, Atishay Jay, Ina Na, et al.
Histopathology|April 17, 2018
DICER1 hot-spot mutations in ovarian gynandroblastomaYemin Wang, Anthony N Karnezis, Jamie Magrill, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 14, 2026
A longitudinal study of research productivity in McGill University's MD-PhD and Clinician Investigator Program Graduates from 2000 to 2017Jamie Magrill, Jean-Pierre Falet, Ella Boone, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
Breast Cancer Research and Treatment|July 21, 2020
Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancerSvetlana Bortnik, Basile Tessier-Cloutier, Samuel Leung, et al.
The American Journal of Surgical Pathology|April 16, 2019
DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell TumorsAnthony N Karnezis, Yemin Wang, Jacqueline Keul, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-AnalysisMatthew Dankner, Laurie-Rose Dubé, Mark Sorin, et al.
Pageof 2